EU Nations Endorse EUUS Data Framework Setting Stage for Formal Adoption India Expands Fuel Dispenser Verification to Hydrogen CNG LNG Amid Clean Energy Transition Standard Chartered to Cut Over 15 of Corporate Functions Roles Amid Efficiency Drive Credit Suisses Neelkanth Mishra Sees Scope for Repo Rate to Hit Decade Low Expects Market PickUp from December Roundhill Memory ETF Surges to Record 98 Billion as AIDriven Demand Fuels Chip Bottleneck Aequs Reports 33 Revenue Surge in FY26 Net Loss Widens Amid Consumer Electronics Expansion NATR Q1 2026 Earnings Strong EPS Surprise Amid Quiet Revenue Disclosures IRM Q1 2026 Earnings Strong EPS Beat Highlights Resilient REIT Performance IMCC Q1 2026 Earnings Negative EPS Reported Amid Limited Disclosure Shares Dip 5 SCCE Q1 2026 Earnings Massive EPS Miss Signals Operational Challenges Ashland Inc ASH Q1 2026 Earnings EPS Misses Estimates Amid Mixed Operating Conditions RMBS Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Despite Shortfall ProQR Therapeutics PRQR Holds Steady Near 157 as Uplift Potential Remains Farmmi Inc FAMI Holds Near Key Support After Modest Decline CPI Aerostructures CVU Edges Higher Testing Key Resistance Near 524 Luda Technology Rallies 4 as Shares Test Key Resistance Near 488 GDL Fund GDL Holds Steady at 847 as Consolidation Persists Netanyahu Orders Escalation of Military Action Against Hizbollah Amid Iran Deal Concerns CHCT Q1 2026 Earnings Massive EPS Surprise Masks Concerns as Stock Slips Lionheart Holdings CUB Consolidates at 1080 Key Levels Define the Next Move Proficient Auto Logistics Inc PAL Q1 2026 Earnings Massive EPS Surprise Despite Revenue Uncertainty UPWK Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction AM Q1 2026 Earnings EPS Misses Estimates Stock Declines 149 Youdao Inc Q1 2026 Earnings EPS Misses Estimates but Stock Surges on Broader Sentiment Lisata Therapeutics Q3 2025 Earnings NarrowerthanExpected Loss as Biotech Advances Clinical Pipeline NVAX Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Higher GH Research Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Clinical Development